Log In
BCIQ
Print this Print this
 

LCI699

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionAldosterone synthase inhibitor
Molecular Target Aldosterone synthase (ALDOS) (CYP11B2)
Mechanism of ActionAldosterone synthase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationCushing's disease
Indication DetailsTreat Cushing's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today